| 분자 | Cat. No. | Product Name | Host Species | Reactive Species | Applications | 규격 및 가격 |
|---|---|---|---|---|---|---|
| NoV(GII.13)VP1 | Monoclonal Anti-Human NoV(GII.13)VP1 Antibody, Mouse IgG1 (2B10) | Mouse | Virus | $400.00 100ug |
| 영어 이름 | 연구 코드 | 연구 개발 단계 | 회사 | 적응증 | 임상 시험 |
|---|---|---|---|---|---|
| SHR-9146 | HTI-1090; SHR-9146 | Phase 1 Clinical | Solid tumours; Neoplasms | 상세 | |
| LPM-3480226 | LY-01013; LPM-3480226 | Phase 1 Clinical | Luye Pharma Group Ltd | Solid tumours | 상세 |
| DN-1406131 | DN-131; DN-1406131 | Phase 1 Clinical | Jiangxi Qingfeng Pharmaceutical Industry Co Ltd, Shanghai De Novo Pharmatech Co Ltd | Solid tumours; Melanoma; Carcinoma, Non-Small-Cell Lung | 상세 |